Health Forward Statement on COVID-19
As the global community grapples with COVID-19, the novel strain of coronavirus, reports confirm that cases in the Middle East and North Africa (MENA) continue to rise. Our thoughts are with those affected both in the region and around the world.
The rapid spread of the coronavirus is a major public health threat. The science needed to tackle the challenge presented by COVID-19 will require global partnerships. Stakeholders, in both the public and private sectors, are collaborating to develop timely treatments and vaccines. In the face of global health threats, policies that support innovation are as important as ever.
Working together, we will continue to drive health forward and help treat and prevent the further spread of COVID-19. For more information about inventors of new medicines and vaccines are responding to the coronavirus crisis, please visit the International Federation of Pharmaceutical Manufacturers and Associations and the Pharmaceutical Research and Manufacturers of America.
